Abstract: N.sup.2 -naphthalenesulfonyl-L-arginine esters and amides having the formula ##STR1## or the acid addition salts thereof with a pharmaceutically acceptable acid, wherein R is selected from the class consisting of (1) alkoxy, alkenyloxy, cycloalkoxy and halogenated alkoxy, aralkyloxy, and alkoxy substituted with an alkoxy group; ##STR2## wherein R.sub.1 and R.sub.
Type:
Grant
Filed:
January 19, 1977
Date of Patent:
January 17, 1978
Assignees:
Mitsubishi Chemical Industries Limited, Shosuke Okamoto
Abstract: N.sup.2 -naphthalenesulfonyl-L-arginine esters and amides having the formula ##STR1## or the acid addition salts thereof with a pharmaceutically acceptable acid, wherein R is selected from the class consisting of (1) alkoxy, alkenyloxy, cycloalkoxy and halogenated alkoxy, respectively containing not more than 10 carbon atoms, aralkyloxy of not more than 15 carbon atoms, and alkoxy of not more than 10 carbon atoms substitured with an alkoxy group of not more than 10 carbon atoms; ##STR2## wherein R.sub.1 and R.sub.
Type:
Grant
Filed:
March 29, 1976
Date of Patent:
January 3, 1978
Assignees:
Mitsubishi Chemical Industries Limited, Shosuke Okamoto
Abstract: N.sup.2 -naphthalenesulfonyl-L-arginine esters and amides having the formula ##STR1## or the acid addition salts thereof with a pharmaceutically acceptable acid, wherein R is selected from the class consisting of (1) alkoxy, alkenyloxy, cycloalkoxy and halogenated alkoxy, respectively containing not more than 10 carbon atoms, aralkyloxy of not more than 15 carbon atoms, and alkoxy of not more than 10 carbon atoms substituted with an alkoxy group of not more than 10 carbon atoms; ##STR2## wherein R.sub.1 and R.sub.
Type:
Grant
Filed:
January 19, 1977
Date of Patent:
January 3, 1978
Assignees:
Mitsubishi Chemical Industries Limited, Shosuke Okamoto
Abstract: Substituted trichloroacetamidine derivatives are prepared by reacting an appropriately substituted amine with trichloroacetamidine or a trichloroacetimidate. The substituted amines are 3-aminomethyl indole and 2-acetoxy-3-phenoxy propylamine.
Abstract: Substituted trichloroacetamidine derivatives are prepared by reacting trichloroacetamidine with an appropriately substituted compound also substituted with a suitable leaving group. The leaving groups are halogen, quaternary or tertiary amines, methanesulfonate, toluenesulfonate, and the like.
Abstract: The present invention provides new iodo benzene derivatives which have at least two benzene nuclei and one carboxylic group.These derivatives possess a low toxicity and may be used as X-ray contrast media.
Type:
Grant
Filed:
December 6, 1976
Date of Patent:
December 27, 1977
Assignee:
Laboratoires Andre Guerbet
Inventors:
Guy Tilly, Michel Jean Charles Hardouin, Jean Lautrou
Abstract: The present invention provides new iodo benzene derivatives which have at least two benzene nuclei and one carboxylic group.These derivatives possess a low toxicity and may be used as X-ray contrast media.
Type:
Grant
Filed:
December 3, 1976
Date of Patent:
December 27, 1977
Assignee:
Laboratoires Andre Guerbet
Inventors:
Guy Tilly, Michel Jean Charles Hardouin, Jean Lautrou
Abstract: New carboxylic acid derivatives are proposed for use as agents in the treatment or prevention of arteriosclerosis. 1-(p-chlorophenoxy)-3-(N-phenyl-N-carbomethoxymethylamino)-2-propanol is a typical compound.
Abstract: N.sup.2 -naphthalenesulfonyl-L-arginine esters and amides having the formula ##STR1## or the acid addition salts thereof with a pharmaceutically acceptable acid, wherein R is selected from the class consisting of (1) alkoxy, alkenyloxy, cycloalkoxy and halogenated alkoxy, respectively containing not more than 10 carbon atoms, aralkyloxy of not more than 15 carbon atoms, and alkoxy of not more than 10 carbon atoms substituted with an alkoxy group of not more than 10 carbon atoms; ##STR2## wherein R.sub.1 and R.sub.
Type:
Grant
Filed:
March 29, 1976
Date of Patent:
December 13, 1977
Assignees:
Mitsubishi Chemical Industries Limited, Shosuke Okamoto
Abstract: New N,N'-tetrasubstituted ureas of the formula ##STR1## in which X is oxygen, sulfur or an NR.sup.5 -- or SO.sub.2 --group,R is alkyl or an optionally substituted aryl group, or an optionally substituted aralkyl group,R.sup.1 and R.sup.4 are individually optionally substituted hydrocarbyl which may contain oxygen or sulfur,R.sup.2 is optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkoxy or cycloalkyl,R.sup.3 is alkyl, which may optionally be substituted by halogen, or is alkenyl, orR.sup.2 and R.sup.3 conjointly form an alkylene bridge, which can be interrupted by a hetero-atom, such as O, or N-alkyl group and which forms a heterocyclic ring with the adjoining nitrogen atom,R.sup.1 and R.sup.
Type:
Grant
Filed:
September 10, 1973
Date of Patent:
November 15, 1977
Assignee:
Bayer Aktiengesellschaft
Inventors:
Rudolf Thomas, Wolfgang Kramer, Ludwig Eue, Carl Metzger, Gerhard Jager
Abstract: This invention relates to 10-aza-11,12-secoprostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful as renal vasodilators.